Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications
about
A Rare Case of Myelodysplastic Syndrome with Refractory ThrombocytopeniaCombination of mitoxantrone and etoposide in the treatment of myelodysplastic syndromes transformed into acute myeloid leukemia.Myeloid surface antigen abnormalities in myelodysplasia: relation to prognosis and modification by 13-cis retinoic acid.Refractory myelodysplastic anaemias with hypocellular bone marrow.Primary myelodysplastic syndrome and cancerHuman preleukaemia: do we have a model?Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens.Epidemiological and etiological aspects of myelodysplastic syndromes.The growth of myelodysplastic bone marrow in long-term cultures.A novel factor-dependent human myelodysplastic cell line, MDS92, contains haemopoietic cells of several lineages.Production of fibronectin and adherence to fibronectin by human myeloma cell lines.Establishment and characterization of a novel myeloid cell line from the bone marrow of a patient with the myelodysplastic syndrome.Human cancer DNA fingerprint analysis.Diagnostic and prognostic value of DNA image cytometry in myelodysplasia.Myelodysplastic syndromes (MDS): prognostic factors and scoring systems.A phase II trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes.Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome.
P2860
Q33426917-4CE1C7EC-6240-4CC5-BCEB-9C37642722A9Q33492683-2A236EA7-E1BB-4041-9B7C-F95F0E0A102CQ33837954-6EB98F62-ADC6-4605-A566-6144D965673FQ33839315-E2E9CE63-530B-4F74-AADA-7E06EC0E710EQ34069558-D6BB67D3-EF57-4CF2-8264-79B83700351AQ36027591-CA909018-EA40-4ABE-BD29-4F111A808402Q37143337-DAAFA4FD-2E36-430C-BC0F-8F2E1E5CBAA7Q40507921-1E1A156A-9FB8-4B20-AB51-C0E35F9652DBQ41149543-93A2E1B8-BE74-4AA9-A0CE-F45219743A0BQ41265275-8665CF90-954B-45E0-B04F-9B960AE2EBF8Q41465157-EFBF8097-314C-4D6A-A5FF-EF4F9D1340BCQ41465166-3D1D601D-3B0F-4256-B661-59D3BEC4E95BQ42541391-1D803D24-3E14-451D-A5A1-108BFAC92C78Q42842068-DB67B58B-06FC-40E7-B40D-0CD41B85A5EFQ44673694-9C9BAF6C-A237-4F41-98C7-DD4E025F5D7EQ45415335-A6540604-77D3-428C-AE13-D2D5172D13B5Q46402910-9FC46782-817E-4FC1-8659-6B8A22546AC2Q46960830-7A0B8957-8B6B-4D1F-B2EE-B6B1AC03EE78
P2860
Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Myelodysplastic syndromes: pat ...... ies, and clinical implications
@en
Myelodysplastic syndromes: pat ...... es, and clinical implications.
@nl
type
label
Myelodysplastic syndromes: pat ...... ies, and clinical implications
@en
Myelodysplastic syndromes: pat ...... es, and clinical implications.
@nl
prefLabel
Myelodysplastic syndromes: pat ...... ies, and clinical implications
@en
Myelodysplastic syndromes: pat ...... es, and clinical implications.
@nl
P2860
P356
P1476
Myelodysplastic syndromes: pat ...... ies, and clinical implications
@en
P2093
P2860
P304
P356
10.1136/JCP.38.11.1201
P407
P577
1985-11-01T00:00:00Z